nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Acetylsalicylic acid—TP53—muscle cancer	0.113	0.556	CrCbGaD
Nitazoxanide—Meloxicam—PTGS2—muscle cancer	0.0386	0.189	CrCbGaD
Nitazoxanide—Salsalate—PTGS2—muscle cancer	0.0297	0.146	CrCbGaD
Nitazoxanide—Acetylsalicylic acid—PTGS2—muscle cancer	0.0222	0.109	CrCbGaD
Nitazoxanide—Pelvic pain—Doxorubicin—muscle cancer	0.0134	0.0168	CcSEcCtD
Nitazoxanide—Lung disorder—Methotrexate—muscle cancer	0.0133	0.0167	CcSEcCtD
Nitazoxanide—Lung disorder—Doxorubicin—muscle cancer	0.0115	0.0144	CcSEcCtD
Nitazoxanide—Dysuria—Vincristine—muscle cancer	0.0114	0.0143	CcSEcCtD
Nitazoxanide—Pharyngitis—Dactinomycin—muscle cancer	0.0108	0.0136	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Etoposide—muscle cancer	0.01	0.0126	CcSEcCtD
Nitazoxanide—Chills—Dactinomycin—muscle cancer	0.00977	0.0123	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Vincristine—muscle cancer	0.00968	0.0122	CcSEcCtD
Nitazoxanide—Amenorrhoea—Doxorubicin—muscle cancer	0.00926	0.0116	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Dactinomycin—muscle cancer	0.00879	0.011	CcSEcCtD
Nitazoxanide—Anaemia—Dactinomycin—muscle cancer	0.00876	0.011	CcSEcCtD
Nitazoxanide—Creatinine increased—Doxorubicin—muscle cancer	0.00855	0.0107	CcSEcCtD
Nitazoxanide—Malaise—Dactinomycin—muscle cancer	0.00855	0.0107	CcSEcCtD
Nitazoxanide—Back pain—Vincristine—muscle cancer	0.00819	0.0103	CcSEcCtD
Nitazoxanide—Myalgia—Dactinomycin—muscle cancer	0.00807	0.0101	CcSEcCtD
Nitazoxanide—Discomfort—Dactinomycin—muscle cancer	0.00797	0.01	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Etoposide—muscle cancer	0.00784	0.00985	CcSEcCtD
Nitazoxanide—Anaemia—Vincristine—muscle cancer	0.00783	0.00983	CcSEcCtD
Nitazoxanide—Oedema—Dactinomycin—muscle cancer	0.00774	0.00972	CcSEcCtD
Nitazoxanide—Infection—Dactinomycin—muscle cancer	0.00768	0.00965	CcSEcCtD
Nitazoxanide—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00748	0.00939	CcSEcCtD
Nitazoxanide—Anorexia—Dactinomycin—muscle cancer	0.00737	0.00926	CcSEcCtD
Nitazoxanide—Hypertension—Vincristine—muscle cancer	0.00731	0.00918	CcSEcCtD
Nitazoxanide—Myalgia—Vincristine—muscle cancer	0.00721	0.00906	CcSEcCtD
Nitazoxanide—Chills—Etoposide—muscle cancer	0.00707	0.00888	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00705	0.00885	CcSEcCtD
Nitazoxanide—Oedema—Vincristine—muscle cancer	0.00691	0.00868	CcSEcCtD
Nitazoxanide—Infection—Vincristine—muscle cancer	0.00687	0.00863	CcSEcCtD
Nitazoxanide—Decreased appetite—Dactinomycin—muscle cancer	0.00672	0.00845	CcSEcCtD
Nitazoxanide—Back pain—Etoposide—muscle cancer	0.00664	0.00834	CcSEcCtD
Nitazoxanide—Pain—Dactinomycin—muscle cancer	0.00661	0.00831	CcSEcCtD
Nitazoxanide—Muscle spasms—Etoposide—muscle cancer	0.0066	0.00829	CcSEcCtD
Nitazoxanide—Anorexia—Vincristine—muscle cancer	0.00659	0.00828	CcSEcCtD
Nitazoxanide—Feeling abnormal—Dactinomycin—muscle cancer	0.00637	0.00801	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Etoposide—muscle cancer	0.00636	0.008	CcSEcCtD
Nitazoxanide—Anaemia—Etoposide—muscle cancer	0.00634	0.00797	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00633	0.00795	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.0063	0.00791	CcSEcCtD
Nitazoxanide—Increased appetite—Doxorubicin—muscle cancer	0.00629	0.0079	CcSEcCtD
Nitazoxanide—Insomnia—Vincristine—muscle cancer	0.00625	0.00785	CcSEcCtD
Nitazoxanide—Malaise—Etoposide—muscle cancer	0.00619	0.00777	CcSEcCtD
Nitazoxanide—Body temperature increased—Dactinomycin—muscle cancer	0.00611	0.00768	CcSEcCtD
Nitazoxanide—Abdominal pain—Dactinomycin—muscle cancer	0.00611	0.00768	CcSEcCtD
Nitazoxanide—Loss of consciousness—Etoposide—muscle cancer	0.00603	0.00757	CcSEcCtD
Nitazoxanide—Decreased appetite—Vincristine—muscle cancer	0.00601	0.00755	CcSEcCtD
Nitazoxanide—Hypertension—Etoposide—muscle cancer	0.00592	0.00744	CcSEcCtD
Nitazoxanide—Constipation—Vincristine—muscle cancer	0.00591	0.00742	CcSEcCtD
Nitazoxanide—Pain—Vincristine—muscle cancer	0.00591	0.00742	CcSEcCtD
Nitazoxanide—Discomfort—Etoposide—muscle cancer	0.00577	0.00725	CcSEcCtD
Nitazoxanide—Hypersensitivity—Dactinomycin—muscle cancer	0.0057	0.00716	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Vincristine—muscle cancer	0.00565	0.0071	CcSEcCtD
Nitazoxanide—Infection—Etoposide—muscle cancer	0.00556	0.00699	CcSEcCtD
Nitazoxanide—Asthenia—Dactinomycin—muscle cancer	0.00555	0.00697	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Doxorubicin—muscle cancer	0.00553	0.00695	CcSEcCtD
Nitazoxanide—Dysuria—Methotrexate—muscle cancer	0.00551	0.00693	CcSEcCtD
Nitazoxanide—Tachycardia—Etoposide—muscle cancer	0.00546	0.00686	CcSEcCtD
Nitazoxanide—Body temperature increased—Vincristine—muscle cancer	0.00546	0.00686	CcSEcCtD
Nitazoxanide—Abdominal pain—Vincristine—muscle cancer	0.00546	0.00686	CcSEcCtD
Nitazoxanide—Anorexia—Etoposide—muscle cancer	0.00534	0.0067	CcSEcCtD
Nitazoxanide—Diarrhoea—Dactinomycin—muscle cancer	0.00529	0.00665	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00521	0.00655	CcSEcCtD
Nitazoxanide—Influenza—Doxorubicin—muscle cancer	0.00511	0.00641	CcSEcCtD
Nitazoxanide—Hypersensitivity—Vincristine—muscle cancer	0.00509	0.0064	CcSEcCtD
Nitazoxanide—Somnolence—Etoposide—muscle cancer	0.00498	0.00625	CcSEcCtD
Nitazoxanide—Epistaxis—Methotrexate—muscle cancer	0.00496	0.00623	CcSEcCtD
Nitazoxanide—Asthenia—Vincristine—muscle cancer	0.00496	0.00623	CcSEcCtD
Nitazoxanide—Vomiting—Dactinomycin—muscle cancer	0.00492	0.00618	CcSEcCtD
Nitazoxanide—Rash—Dactinomycin—muscle cancer	0.00488	0.00613	CcSEcCtD
Nitazoxanide—Decreased appetite—Etoposide—muscle cancer	0.00487	0.00611	CcSEcCtD
Nitazoxanide—Pain—Etoposide—muscle cancer	0.00479	0.00601	CcSEcCtD
Nitazoxanide—Constipation—Etoposide—muscle cancer	0.00479	0.00601	CcSEcCtD
Nitazoxanide—Dysuria—Doxorubicin—muscle cancer	0.00477	0.006	CcSEcCtD
Nitazoxanide—Diarrhoea—Vincristine—muscle cancer	0.00473	0.00594	CcSEcCtD
Nitazoxanide—Pharyngitis—Methotrexate—muscle cancer	0.00468	0.00589	CcSEcCtD
Nitazoxanide—Feeling abnormal—Etoposide—muscle cancer	0.00461	0.0058	CcSEcCtD
Nitazoxanide—Nausea—Dactinomycin—muscle cancer	0.00459	0.00577	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Etoposide—muscle cancer	0.00458	0.00575	CcSEcCtD
Nitazoxanide—Dizziness—Vincristine—muscle cancer	0.00457	0.00574	CcSEcCtD
Nitazoxanide—Abdominal pain—Etoposide—muscle cancer	0.00443	0.00556	CcSEcCtD
Nitazoxanide—Body temperature increased—Etoposide—muscle cancer	0.00443	0.00556	CcSEcCtD
Nitazoxanide—Vomiting—Vincristine—muscle cancer	0.00439	0.00552	CcSEcCtD
Nitazoxanide—Rash—Vincristine—muscle cancer	0.00436	0.00547	CcSEcCtD
Nitazoxanide—Dermatitis—Vincristine—muscle cancer	0.00435	0.00547	CcSEcCtD
Nitazoxanide—Headache—Vincristine—muscle cancer	0.00433	0.00544	CcSEcCtD
Nitazoxanide—Epistaxis—Doxorubicin—muscle cancer	0.00429	0.00539	CcSEcCtD
Nitazoxanide—Chills—Methotrexate—muscle cancer	0.00424	0.00532	CcSEcCtD
Nitazoxanide—Hypersensitivity—Etoposide—muscle cancer	0.00412	0.00518	CcSEcCtD
Nitazoxanide—Nausea—Vincristine—muscle cancer	0.00411	0.00516	CcSEcCtD
Nitazoxanide—Rhinitis—Doxorubicin—muscle cancer	0.0041	0.00515	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Doxorubicin—muscle cancer	0.00407	0.00511	CcSEcCtD
Nitazoxanide—Pharyngitis—Doxorubicin—muscle cancer	0.00406	0.0051	CcSEcCtD
Nitazoxanide—Asthenia—Etoposide—muscle cancer	0.00402	0.00505	CcSEcCtD
Nitazoxanide—Back pain—Methotrexate—muscle cancer	0.00397	0.00499	CcSEcCtD
Nitazoxanide—Pruritus—Etoposide—muscle cancer	0.00396	0.00498	CcSEcCtD
Nitazoxanide—Diarrhoea—Etoposide—muscle cancer	0.00383	0.00481	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Methotrexate—muscle cancer	0.00381	0.00479	CcSEcCtD
Nitazoxanide—Anaemia—Methotrexate—muscle cancer	0.0038	0.00477	CcSEcCtD
Nitazoxanide—Malaise—Methotrexate—muscle cancer	0.00371	0.00465	CcSEcCtD
Nitazoxanide—Dizziness—Etoposide—muscle cancer	0.0037	0.00465	CcSEcCtD
Nitazoxanide—Chills—Doxorubicin—muscle cancer	0.00367	0.00461	CcSEcCtD
Nitazoxanide—Vomiting—Etoposide—muscle cancer	0.00356	0.00447	CcSEcCtD
Nitazoxanide—Rash—Etoposide—muscle cancer	0.00353	0.00443	CcSEcCtD
Nitazoxanide—Dermatitis—Etoposide—muscle cancer	0.00353	0.00443	CcSEcCtD
Nitazoxanide—Headache—Etoposide—muscle cancer	0.00351	0.00441	CcSEcCtD
Nitazoxanide—Flatulence—Doxorubicin—muscle cancer	0.00351	0.0044	CcSEcCtD
Nitazoxanide—Myalgia—Methotrexate—muscle cancer	0.0035	0.00439	CcSEcCtD
Nitazoxanide—Discomfort—Methotrexate—muscle cancer	0.00346	0.00434	CcSEcCtD
Nitazoxanide—Back pain—Doxorubicin—muscle cancer	0.00344	0.00432	CcSEcCtD
Nitazoxanide—Muscle spasms—Doxorubicin—muscle cancer	0.00342	0.0043	CcSEcCtD
Nitazoxanide—Infection—Methotrexate—muscle cancer	0.00333	0.00419	CcSEcCtD
Nitazoxanide—Nausea—Etoposide—muscle cancer	0.00333	0.00418	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Doxorubicin—muscle cancer	0.0033	0.00415	CcSEcCtD
Nitazoxanide—Anaemia—Doxorubicin—muscle cancer	0.00329	0.00413	CcSEcCtD
Nitazoxanide—Malaise—Doxorubicin—muscle cancer	0.00321	0.00403	CcSEcCtD
Nitazoxanide—Anorexia—Methotrexate—muscle cancer	0.0032	0.00402	CcSEcCtD
Nitazoxanide—Syncope—Doxorubicin—muscle cancer	0.00319	0.00401	CcSEcCtD
Nitazoxanide—Loss of consciousness—Doxorubicin—muscle cancer	0.00313	0.00393	CcSEcCtD
Nitazoxanide—Hypertension—Doxorubicin—muscle cancer	0.00307	0.00386	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00306	0.00384	CcSEcCtD
Nitazoxanide—Insomnia—Methotrexate—muscle cancer	0.00303	0.00381	CcSEcCtD
Nitazoxanide—Myalgia—Doxorubicin—muscle cancer	0.00303	0.00381	CcSEcCtD
Nitazoxanide—Discomfort—Doxorubicin—muscle cancer	0.00299	0.00376	CcSEcCtD
Nitazoxanide—Somnolence—Methotrexate—muscle cancer	0.00298	0.00375	CcSEcCtD
Nitazoxanide—Dry mouth—Doxorubicin—muscle cancer	0.00296	0.00372	CcSEcCtD
Nitazoxanide—Dyspepsia—Methotrexate—muscle cancer	0.00295	0.00371	CcSEcCtD
Nitazoxanide—Decreased appetite—Methotrexate—muscle cancer	0.00292	0.00366	CcSEcCtD
Nitazoxanide—Oedema—Doxorubicin—muscle cancer	0.0029	0.00365	CcSEcCtD
Nitazoxanide—Infection—Doxorubicin—muscle cancer	0.00288	0.00362	CcSEcCtD
Nitazoxanide—Pain—Methotrexate—muscle cancer	0.00287	0.0036	CcSEcCtD
Nitazoxanide—Shock—Doxorubicin—muscle cancer	0.00286	0.00359	CcSEcCtD
Nitazoxanide—Tachycardia—Doxorubicin—muscle cancer	0.00283	0.00356	CcSEcCtD
Nitazoxanide—Anorexia—Doxorubicin—muscle cancer	0.00277	0.00348	CcSEcCtD
Nitazoxanide—Feeling abnormal—Methotrexate—muscle cancer	0.00276	0.00347	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Methotrexate—muscle cancer	0.00274	0.00344	CcSEcCtD
Nitazoxanide—Abdominal pain—Methotrexate—muscle cancer	0.00265	0.00333	CcSEcCtD
Nitazoxanide—Body temperature increased—Methotrexate—muscle cancer	0.00265	0.00333	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00265	0.00332	CcSEcCtD
Nitazoxanide—Insomnia—Doxorubicin—muscle cancer	0.00263	0.0033	CcSEcCtD
Nitazoxanide—Somnolence—Doxorubicin—muscle cancer	0.00258	0.00324	CcSEcCtD
Nitazoxanide—Dyspepsia—Doxorubicin—muscle cancer	0.00256	0.00321	CcSEcCtD
Nitazoxanide—Decreased appetite—Doxorubicin—muscle cancer	0.00252	0.00317	CcSEcCtD
Nitazoxanide—Pain—Doxorubicin—muscle cancer	0.00248	0.00312	CcSEcCtD
Nitazoxanide—Constipation—Doxorubicin—muscle cancer	0.00248	0.00312	CcSEcCtD
Nitazoxanide—Hypersensitivity—Methotrexate—muscle cancer	0.00247	0.0031	CcSEcCtD
Nitazoxanide—Asthenia—Methotrexate—muscle cancer	0.00241	0.00302	CcSEcCtD
Nitazoxanide—Feeling abnormal—Doxorubicin—muscle cancer	0.00239	0.00301	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00237	0.00298	CcSEcCtD
Nitazoxanide—Pruritus—Methotrexate—muscle cancer	0.00237	0.00298	CcSEcCtD
Nitazoxanide—Abdominal pain—Doxorubicin—muscle cancer	0.0023	0.00288	CcSEcCtD
Nitazoxanide—Body temperature increased—Doxorubicin—muscle cancer	0.0023	0.00288	CcSEcCtD
Nitazoxanide—Diarrhoea—Methotrexate—muscle cancer	0.00229	0.00288	CcSEcCtD
Nitazoxanide—Dizziness—Methotrexate—muscle cancer	0.00222	0.00279	CcSEcCtD
Nitazoxanide—Hypersensitivity—Doxorubicin—muscle cancer	0.00214	0.00269	CcSEcCtD
Nitazoxanide—Vomiting—Methotrexate—muscle cancer	0.00213	0.00268	CcSEcCtD
Nitazoxanide—Rash—Methotrexate—muscle cancer	0.00211	0.00266	CcSEcCtD
Nitazoxanide—Dermatitis—Methotrexate—muscle cancer	0.00211	0.00265	CcSEcCtD
Nitazoxanide—Headache—Methotrexate—muscle cancer	0.0021	0.00264	CcSEcCtD
Nitazoxanide—Asthenia—Doxorubicin—muscle cancer	0.00208	0.00262	CcSEcCtD
Nitazoxanide—Pruritus—Doxorubicin—muscle cancer	0.00205	0.00258	CcSEcCtD
Nitazoxanide—Nausea—Methotrexate—muscle cancer	0.00199	0.0025	CcSEcCtD
Nitazoxanide—Diarrhoea—Doxorubicin—muscle cancer	0.00199	0.0025	CcSEcCtD
Nitazoxanide—Dizziness—Doxorubicin—muscle cancer	0.00192	0.00241	CcSEcCtD
Nitazoxanide—Vomiting—Doxorubicin—muscle cancer	0.00185	0.00232	CcSEcCtD
Nitazoxanide—Rash—Doxorubicin—muscle cancer	0.00183	0.0023	CcSEcCtD
Nitazoxanide—Dermatitis—Doxorubicin—muscle cancer	0.00183	0.0023	CcSEcCtD
Nitazoxanide—Headache—Doxorubicin—muscle cancer	0.00182	0.00229	CcSEcCtD
Nitazoxanide—Nausea—Doxorubicin—muscle cancer	0.00172	0.00217	CcSEcCtD
